<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antibiotic dosing for invasive &lt;em&gt;Listeria&lt;/em&gt; infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antibiotic dosing for invasive <em>Listeria</em> infection</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antibiotic dosing for invasive <em>Listeria</em> infection</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Infants ≤7 days of age</td> <td class="subtitle1">Infants 8 to 28 days of age</td> <td class="subtitle1">Infants 29 to 60 days of age</td> <td class="subtitle1">Infants and children &gt;60 days of age</td> <td class="subtitle1">Nonpregnant adults</td> </tr> <tr> <td>Ampicillin</td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>300 mg/kg per day IV in 3 divided doses</li> </ul> Patients in whom CNS infection has been excluded (weight-directed dosing)*: <ul class="decimal_heading"> <li>Weight ≤2 kg: 100 mg/kg per day IV in 2 divided doses</li> <li>Weight &gt;2 kg: 150 mg/kg per day IV in 3 divided doses</li> </ul> </td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>300 mg/kg per day IV in 4 divided doses</li> </ul> Patients in whom CNS infection has been excluded (weight-directed dosing)*: <ul class="decimal_heading"> <li>Weight ≤2 kg: 150 mg/kg per day IV in 2 divided doses</li> <li>Weight &gt;2 kg: 150 mg/kg per day IV in 3 divided doses</li> </ul> </td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>300 mg/kg per day IV in 4 divided doses</li> </ul> Patients in whom CNS infection has been excluded: <ul class="decimal_heading"> <li>200 mg/kg per day IV in 4 divided doses</li> </ul> </td> <td> <p>Patients in whom CNS infection has been documented or not yet excluded:</p> <ul> <li>300 to 400 mg/kg per day IV in 4 to 6 divided doses; maximum dose: 12 g per day</li> </ul> <p>Patients in whom CNS infection has been excluded:</p> <ul> <li>200 mg/kg per day IV in 4 divided doses; maximum dose: 8 g per day</li> </ul> </td> <td>2 g IV every 4 hours</td> </tr> <tr> <td class="indent1" colspan="6"><strong>or</strong></td> </tr> <tr> <td>Penicillin G</td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>450,000 units/kg/day IV in 3 divided doses</li> </ul> Patients in whom CNS infection has been excluded: <ul class="decimal_heading"> <li>100,000 units/kg/day IV in 2 divided doses</li> </ul> </td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>400,000 to 500,000 units/kg/day IV in 4 divided doses</li> </ul> Patients in whom CNS infection has been excluded: <ul class="decimal_heading"> <li>150,000 units/kg/day IV in 3 divided doses</li> </ul> </td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>400,000 to 500,000 units/kg/day IV in 4 divided doses</li> </ul> Patients in whom CNS infection has been excluded: <ul class="decimal_heading"> <li>200,000 units/kg/day IV in 4 divided doses</li> </ul> </td> <td>Patients in whom CNS infection has been documented or not yet excluded: <ul class="decimal_heading"> <li>400,000 to 500,000 units/kg per day IV in 4 to 6 divided doses; maximum dose: 24 million units per day; doses &gt;400,000 units/kg per day are generally only used for infants &lt;1 year of age</li> </ul> Patients in whom CNS infection has been excluded: <ul class="decimal_heading"> <li>250,000 to 300,000 units/kg/day IV in 4 to 6 divided doses; maximum dose: 24 million units per day</li> </ul> </td> <td>4 million units IV every 4 hours</td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="6"><strong>plus</strong> (if CNS, bloodstream, or other serious infection)</td> </tr> <tr> <td class="subtitle1"> </td> <td class="subtitle1" colspan="3">Infants ≤60 days of age</td> <td class="subtitle1">Infants and children &gt;60 days of age</td> <td class="subtitle1">Nonpregnant adults</td> </tr> <tr> <td>Gentamicin<sup>¶</sup></td> <td colspan="3">Gestational age &lt;30 weeks: <ul class="decimal_heading"> <li>Postnatal age ≤14 days: 5 mg/kg IV every 48 hours</li> <li>Postnatal age &gt;14 days: 5 mg/kg IV every 36 hours</li> </ul> Gestational age 30 to 34 weeks: <ul class="decimal_heading"> <li>Postnatal age ≤10 days: 5 mg/kg IV every 36 hours</li> <li>Postnatal age &gt;10 to 60 days: 5 mg/kg IV every 24 to 36 hours</li> </ul> Gestational age ≥35 weeks: <ul class="decimal_heading"> <li>Postnatal age ≤7 days: 4 mg/kg IV every 24 hours</li> <li>Postnatal age &gt;7 to 60 days: 5 mg/kg IV every 24 hours</li> </ul> </td> <td>7.5 mg/kg per day IV in 3 divided doses</td> <td>5 mg/kg per day IV in 3 divided doses</td> </tr> </tbody></table></div><div class="graphic_lgnd">Dosing in this table is for patients with normal renal function; infant dosing is for patients weighing ≥1 kg. For additional dosing detail, refer to the Lexicomp drug information monographs included within UpToDate.</div><div class="graphic_footnotes">CNS: central nervous system; IV: intravenously.<br/>* For alternative gestational age-directed dosing, refer to the Lexicomp pediatric drug information monograph included within UpToDate.<br/>¶ The optimal peak gentamicin levels in listerial infection are not known; the ranges presented are the opinions of our contributors: 

<ul>
<li>For infants to ≤1 month of age, the desired gentamicin peak is 6 to 12 mcg/mL and the trough is &lt;2 mcg/mL.</li>
<li>For infants and children &gt;1 month of age, the desired gentamicin peak is 6 to 10 mcg/mL and the trough is &lt;2 mcg/mL.</li>
<li>For nonpregnant adults, the desired gentamicin peak is 4 to 8 mcg/mL and the trough is &lt;2 mcg/mL (ideally &lt;1 mcg/mL). While the target serum gentamicin peak concentration for synergy of infections outside the CNS is typically 3 to 4 mcg/mL, many favor higher target peak concentrations for treatment of gram-positive CNS infections to achieve adequate concentrations for synergy in the context of limited cerebrospinal fluid penetration; however, the optimal serum peak concentrations are uncertain. Refer to the UpToDate topic on dosing of parenteral aminoglycosides for further discussion.</li></ul></div><div class="graphic_reference">Data from: 
<ul>
<li>American Academy of Pediatrics. Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021.</li>
<li>Medications. In: Guidelines for Acute Care of the Neonate, 26th Ed, Fernandes CJ, Pammi M, Katakam L (Eds), Baylor College of Medicine, Houston, TX 2018. p.228.</li>
<li>Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</li></ul></div><div id="graphicVersion">Graphic 122593 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
